Gene Expression Analysis of the Activating Factor 3/Nuclear Protein 1 Axis in a Non-alcoholic Steatohepatitis Mouse Model

被引:10
|
作者
Nagahara, Ran [1 ]
Matono, Tomomitsu [1 ]
Sugihara, Takaaki [1 ]
Matsuki, Yukako [1 ]
Yamane, Masafumi [1 ]
Okamoto, Toshiaki [1 ]
Miyoshi, Kenichi [1 ]
Nagahara, Takakazu [1 ]
Okano, Jun-ichi [1 ]
Koda, Masahiko [1 ]
Isomoto, Hajime [1 ]
机构
[1] Tottori Univ, Fac Med, Div Med & Clin Sci, Dept Multidisciplinary Internal Med,Sch Med, Yonago, Tottori 6838504, Japan
关键词
endoplasmic reticulum stress; mouse model; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; PATHOGENESIS; ATF3; P8; REGULATOR; PATHWAYS; ACTS; MICE; TNF;
D O I
10.33160/yam.2019.03.006
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Nonalcoholic fatty liver disease/steatohepatitis (NAFLD/NASH) is a chronic liver disease related to metabolic syndrome that can progress to liver cirrhosis. The involvement of the endoplasmic reticulum (ER) stress response in NAFLD progression and the roles played by activating factor 3 (ATF3) and the downstream nuclear protein 1 (NUPR1) are poorly understood. The aim of this study was to determine the gene expression profiles around the ATF3/NUPR1 axis in relation to the development of NAFLD using novel mouse models. Methods Fatty liver Shionogi (FLS) mice (n = 12) as a NAFLD model and FLS-ob/ob mice (n = 28) as a NASH model were fed a standard diet. The FLS mice were sacrificed at 24 weeks of age as a control, whereas the FLS-ob/ob mice were sacrificed at 24, 36, and 48 weeks of age. Hepatic steatosis, inflammation, and fibrosis were evaluated by biochemical, histological, and gene expression analyses. The expression levels of the ER-stress related genes Jun proto-oncogene (C-jun), Atf3, Nupr1, and C/EBP homologous protein (Chop) were measured in liver tissue. Apoptosis was evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Results Control mice demonstrated hepatic steatosis alone without apparent fibrosis. On the other hand, FLS-ob/ob mice showed severe steatohepatitis at both 24 and 36 weeks of age and severe fibrosis at both 36 and 48 weeks of age. The expression levels of Atf3, Nupr-1, and C-jun significantly increased from 24 to 48 weeks of age in FLS-ob/ob mice compared with control mice. The expression level of Chop was already high in FLS mice and maintained similar levels in FLS-ob/ob mice; the expression level was consistent with the percentage of TUNEL-positive cells. Conclusion The ATF3/NUPR1 axis plays a pivotal role in NASH progression in association with C-jun and Chop and appears to induce apoptosis from early steatosis in the NASH model mice.
引用
下载
收藏
页码:36 / 46
页数:11
相关论文
共 50 条
  • [1] A mouse model for Non-alcoholic Steatohepatitis
    Sundaresan, Sinju
    Vijayagopal, Parakat
    Mills, Nathaniel
    Imrhan, Victorine
    Prasad, Chandan
    FASEB JOURNAL, 2010, 24
  • [2] Perturbed liver gene zonation in a mouse model of non-alcoholic steatohepatitis
    Zhou, Ye
    Zhao, Yuanqi
    Carbonaro, Marisa
    Chen, Helen
    Germino, Mary
    Adler, Christina
    Ni, Min
    Zhu, Yuan O.
    Kim, Sun Y.
    Altarejos, Judith
    Li, Zhe
    Burczynski, Michael E.
    Glass, David J.
    Sleeman, Mark W.
    Lee, Ann-Hwee
    Halasz, Gabor
    Cheng, Xiping
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 154
  • [3] B-cell activating factor in non-alcoholic steatohepatitis
    Mir, Iris Gines
    Kumar, Raju
    Garrido, Patricia
    Li, Wenhao
    Miller, Hamish
    Saihi, Hajar
    Hood, Gillian
    Alazawi, William
    JOURNAL OF HEPATOLOGY, 2023, 78 : S825 - S825
  • [4] A Novel Mouse Model of Accelerated Non-Alcoholic Steatohepatitis
    Malhotra, P.
    Han, E.
    Ooka, K.
    Muthusamy, S.
    Gill, R.
    Dudeja, P.
    Aloman, C.
    Alrefai, W.
    FASEB JOURNAL, 2015, 29
  • [5] Chemerin in a Mouse Model of Non-alcoholic Steatohepatitis and Hepatocarcinogenesis
    Haberl, Elisabeth M.
    Pohl, Rebekka
    Rein-Fischboeck, Lisa
    Feder, Susanne
    Sinal, Christopher J.
    Buechler, Christa
    ANTICANCER RESEARCH, 2018, 38 (05) : 2649 - 2657
  • [6] Gene expression in obese patients with non-alcoholic steatohepatitis
    Cayon, A.
    Crespo, J.
    Guerra, A. R.
    Pons-Romero, F.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2008, 100 (04) : 212 - 218
  • [7] Hepatic gene expression in non-alcoholic steatohepatitis (NASH).
    Sreekumar, R
    Nagorney, DM
    Wiesner, R
    Rosen, C
    Charlton, M
    HEPATOLOGY, 2000, 32 (04) : 417A - 417A
  • [8] Upregulation of cancer-associated gene expression in activated fibroblasts in a mouse model of non-alcoholic steatohepatitis
    Asakawa, Masahiro
    Itoh, Michiko
    Suganami, Takayoshi
    Sakai, Takeru
    Kanai, Sayaka
    Shirakawa, Ibuki
    Yuan, Xunmei
    Hatayama, Tomomi
    Shimada, Shu
    Akiyama, Yoshimitsu
    Fujiu, Katsuhito
    Inagaki, Yutaka
    Manabe, Ichiro
    Yamaoka, Shoji
    Yamada, Tetsuya
    Tanaka, Shinji
    Ogawa, Yoshihiro
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Upregulation of cancer-associated gene expression in activated fibroblasts in a mouse model of non-alcoholic steatohepatitis
    Masahiro Asakawa
    Michiko Itoh
    Takayoshi Suganami
    Takeru Sakai
    Sayaka Kanai
    Ibuki Shirakawa
    Xunmei Yuan
    Tomomi Hatayama
    Shu Shimada
    Yoshimitsu Akiyama
    Katsuhito Fujiu
    Yutaka Inagaki
    Ichiro Manabe
    Shoji Yamaoka
    Tetsuya Yamada
    Shinji Tanaka
    Yoshihiro Ogawa
    Scientific Reports, 9
  • [10] Increased 53-binding protein 1 nuclear focus expression in patients with non-alcoholic steatohepatitis
    Okamoto, Koji
    Akazawa, Yuko
    Miyaaki, Hisamitsu
    Miuma, Satoshi
    Taura, Naota
    Kondo, Hisayoshi
    Nakashima, Masahiro
    Nakao, Kazuhiko
    HEPATOLOGY, 2015, 62 : 677A - 677A